12
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Prevention and resolution of airway obstruction

Pages 9-11 | Published online: 25 Feb 2005

Reference

  • AHRENS RC et al.: Use of bronchial provocation with histamine to compare the pharmacodynamics of inhaled albuterol and metaproterenol in patients with asthma. J. Allergy. Clin. Immunol. (1987) 79:876-882.
  • JENNE JW et al.: Pharmacokinetics of beta-adrenergic compounds In: Drug Therapy for Asthma; Research and Clinical Practice. JW Jenne, S Murphy (Eds.), Marcel Dekker, Inc., New York (1987):213-258.
  • HOSHIKO K et al.: Exacerbation of airway hyperreactivity by racemic salbutamol in sensitized guinea-pigs. Jpn, I. PharmacoL (1993) 63:159–163.
  • MAllONI L et al.: Hyperresponsiveness of the airways to histamine following exposure of guinea-pigs to racemic mixtures and distomers of beta2-selective sympathomimetics. Pulm. Pharmacol. (1994) 7:367–376.
  • MORLEY J: Anomalous effects of albuterol and other sympathomimetics in the guinea pig. Clin. Rev. Allergy lmmunol. (1996) 14:65–89.
  • CROWTHER SD et al.: Varied effects of regular salbutamol on airway responsiveness to inhaled spasmogens. Lancet (1997) 350:1450.
  • CROWTHER SD et al.: Heterogeneity of airway hyperresponsiveness. Clin. Exp. Allergy (1997) 27:606–616.
  • HANDLEY DA et al.: Sympathomimetic enantiomers and asthma. Chirality (1998) 10: 262–272.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.